Avigan® Shows Promising Results in Treatment of COVID Patients in Japan
Completed Phase 3 clinical study paves way for approval request Healthcare solutions provider Global Response Aid (GRA) and Dr. Reddy’s Laboratories (NYSE: RDY) announced that the anti-viral drug Avigan® produced …
